Numira Biosciences Gets $3.2M

Irvine-based Numira Biosciences, a contract research organization focused on high resolution imaging, has raised $3.2M in a funding round, according to a recent regulatory filing by the firm. No details on the funding have been announced by the company. Numira has previously raised funding from the Pasadena Angels, Tech Coast Angels and vSpring Capital. Paul DeRidder, of Crystal Cove Capital and a member of the TCA, sits on the board, as does Dinesh Patel of vSpring. More information »